GLOBUS MEDICAL, INC. Deferred Tax Assets, Valuation Allowance
GLOBUS MEDICAL, INC. (GMED) had Deferred Tax Assets, Valuation Allowance of $139.17 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-02-24
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $139.17M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $182.61M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $190.76M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $5.49M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2025-12-31 | $139.17M 10-K · filed 2026-02-24 |
| 2024-12-31 | $182.61M 10-K · filed 2026-02-24 |
| 2023-12-31 | $190.76M 10-K · filed 2025-02-20 |
| 2022-12-31 | $5.49M 10-K · filed 2024-02-21 |
| 2021-12-31 | $6.59M 10-K · filed 2023-02-21 |
| 2020-12-31 | $6.49M 10-K · filed 2022-02-17 |
| 2019-12-31 | $2.85M 10-K · filed 2021-02-17 |
| 2018-12-31 | $2.68M 10-K/A · filed 2020-03-02 |
| 2017-12-31 | $1.82M 10-K · filed 2019-02-21 |
| 2016-12-31 | $83.00K 10-K · filed 2018-02-22 |
| 2015-12-31 | $43.00K 10-K · filed 2017-03-16 |
| 2014-12-31 | $45.00K 10-K · filed 2016-02-29 |
| 2013-12-31 | $327.00K 10-K · filed 2015-02-26 |
| 2012-12-31 | $533.00K 10-K · filed 2014-03-14 |
| 2011-12-31 | $1.15M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |